In vivo imaging of intraperitoneally disseminated tumors in model mice by using activatable fluorescent small-molecular probes for activity of cathepsins

Bioconjugate Chemistry

Volumn 25, Issue 10, 2014, Pages 1838-1846

  Fujii, Tomohiko ^a   Kamiya, Mako ^a   Urano, Yasuteru ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL CULTURE; CELLS; DISEASES; FLUORESCENCE; MAMMALS; PH; PHYSIOLOGY; PROBES;

CANCER CELL LINES; CANCER CELLS; CANCEROUS LESIONS; FLUORESCENCE PROBES; FLUORESCENCE RATIO; HUMAN EYE; IN-VIVO; IN-VIVO IMAGING; INTRAPERITONEALLY; MOLECULAR PROBES;

TUMORS;

CATHEPSIN; CATHEPSIN B; CATHEPSIN L; FLUORESCENT DYE; HYDROXYMETHYLRHODAMINE GREEN; UNCLASSIFIED DRUG; ARGINYLARGININE; DIPEPTIDE; MOLECULAR PROBE; PHENYLALANYLARGININE; RHODAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DISSEMINATED CANCER; DRUG STRUCTURE; FLUORESCENCE IMAGING; HUMAN; IN VIVO STUDY; MOLECULAR LIBRARY; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; PH; PROTEIN EXPRESSION; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; FEMALE; METABOLISM; MOLECULAR PROBE; OVARIAN NEOPLASMS; PATHOLOGY; PERITONEAL NEOPLASMS; PERITONEUM; SECONDARY; TUMOR CELL LINE;

ANIMALS; CATHEPSINS; CELL LINE, TUMOR; DIPEPTIDES; FEMALE; FLUORESCENT DYES; HUMANS; MICE; MOLECULAR PROBES; OPTICAL IMAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PERITONEUM; RHODAMINES;

EID: 84908027439     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc5003289     Document Type: Article

References (52)

1. Frangioni, J. V. (2008) New technologies for human cancer imaging J. Clin. Oncol. 26, 4012-4021
2. Weissleder, R. and Pittet, M. J. (2008) Imaging in the era of molecular oncology Nature 452, 580-589
3. Urano, Y., Sakabe, M., Kosaka, N., Ogawa, M., Mitsunaga, M., Asanuma, D., Kamiya, M., Young, M. R., Nagano, T., Choyke, P. L., and Kobayashi, H. (2011) Rapid cancer detection by topically spraying a γ-glutamyltranspeptidase-activated fluorescent probe Sci. Transl. Med. 3, 110ra119
4. Kobayashi, H., Ogawa, M., Alford, R., Choyke, P. L., and Urano, Y. (2010) New strategies for fluorescent probe design in medical diagnostic imaging Chem. Rev. 110, 2620-2640
5. Sakabe, M., Asanuma, D., Kamiya, M., Iwatate, R. J., Hanaoka, K., Terai, T., Nagano, T., and Urano, Y. (2013) Rational design of highly sensitive fluorescence probes for protease and glycosidase based on precisely controlled spirocyclization J. Am. Chem. Soc. 135, 409-414
6. Koblinski, J. E., Ahram, M., and Sloane, B. F. (2000) Unraveling the role of proteases in cancer Clin. Chim. Acta 291, 113-135
7. Mason, S. D. and Joyce, J. A. (2011) Proteolytic networks in cancer Trends Cell Biol. 21, 228-237
8. Podgorski, I. and Sloane, B. F. (2003) Cathepsin B and its role(s) in cancer progression Biochem. Soc. Symp. 70, 263-276
9. Gondi, C. S. and Rao, J. S. (2013) Cathepsin B as a cancer target Expert Opin. Ther. Targets 17, 281-291
10. Lankelma, J. M., Voorend, D. M., Barwari, T., Koetsveld, J., Van der Spek, A. H., De Porto, A. P., Van Rooijen, G., and Van Noorden, C. J. (2010) Cathepsin L, target in cancer treatment? Life Sci. 86, 225-233
11. Leto, G., Sepporta, M. V., Crescimanno, M., Flandina, C., and Tumminello, F. M. (2010) Cathepsin L in metastatic bone disease: therapeutic implications Biol. Chem. 39, 655-664
12. Mai, J., Waisman, D. M., and Sloane, B. F. (2000) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression Biochim. Biophys. Acta 1477, 215-230
13. Bengsch, F., Buck, A., Günther, S. C., Seiz, J. R., Tacke, M., Pfeifer, D., Elverfeldt, D., Sevenich, L., Hillebrand, L. E., Kern, U., Sameni, M., Peters, C., Sloane, B. F., and Reinheckel, T. (2013) Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression Oncogene 1-11
14. Jessup, J. M. (1994) Cathepsin B and other proteases in human colorectal carcinoma Am. J. Pathol. 145, 253-262
15. Keppler, D., Abrahamson, M., and Sordat, B. (1994) Secretion of cathepsin B and tumour invasion Biochem. Soc. Trans. 22, 43-49
16. Ebert, M. P., Krüger, S., Fogeron, M. L., Lamer, S., Chen, J., Pross, M., Schulz, H. U., Lage, H., Heim, S., Roessner, A., Malfertheiner, P., and Röcken, C. (2005) Overexpression of cathepsin B in gastric cancer identified by proteome analysis Proteomics 5, 1693-1704
17. Czyzewska, J., Guzińska-Ustymowicz, K., Kemona, A., and Bandurski, R. (2008) The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis,but not with postoperative survival Folia Histochem. Cytobiol. 46, 57-64
18. Sukoh, N., Abe, S., Ogura, S., Isobe, H., Takekawa, H., Inoue, K., and Kawakami, Y. (1994) Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer Cancer 74, 46-51
19. Sinha, A. A., Wilson, M. J., Gleason, D. F., Reddy, P. K., Sameni, M., and Sloane, B. F. (1995) Immunohistochemical localization of cathepsin B in neoplastic human prostate Prostate 26, 171-178
20. Downs, L. S., Jr., Lima, P. H., Bliss, R. L., and Blomquist, C. H. (2005) Cathepsins B and D activity and activity ratios in normal ovaries, benign ovarian neoplasms, and epithelial ovarian cancer J. Soc. Gynecol. Investig. 12, 539-544
21. Nishikawa, H., Ozaki, Y., Nakanishi, T., Blomgren, K., Tada, T., Arakawa, A., and Suzumori, K. (2004) The role of cathepsin B and cystatin C in the mechanisms of invasion by ovarian cancer Gynecol. Oncol. 92, 881-886
22. Haczyńksa, H., Gerber, J., Osada, J., and Warwas, M. (1997) The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma Acta Biochim. Polym. 44, 113-120
23. Levicar, N., Nuttall, R. K., and Lah, T. T. (2003) Proteases in brain tumour progression Acta Neurochir 145, 825-838
24. Mai, J., Sameni, M., Mikkelsen, T., and Sloane, B. F. (2002) Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas Biol. Chem. 383, 1407-1413
25. Rempel, S. A., Rosenblum, M. L., Mikkelsen, T., Yan, P. S., Ellis, K. D., Golembieski, W. A., Sameni, M., Rozhin, J., Ziegler, G., and Sloane, B. F. (1994) Cathepsin B expression and localization in glioma progression and invasion Cancer Res. 54, 6027-6031
26. Sloane, B. F., Dunn, J. R., and Honn, K. V. (1981) Lysosomal cathepsin B: correlation with metastatic potential Science 212, 1151-1153
27. Page, A. E., Warburton, M. J., Chambers, T. J., Pringle, J. A., and Hayman, A. R. (1992) Human osteoclastomas contain multiple forms of cathepsin B Biochim. Biophys. Acta 1116, 57-66
28. Morita, T., Kato, H., Iwanaga, S., Takada, K., and Kimura, T. (1977) New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase J. Biochem. 82, 1495-1498
29. Barrett, A. J. (1980) Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates Biochem. J. 187, 909-912
30. Barrett, A. J. and Kirschke, H. (1981) Cathepsin B, cathepsin H, and cathepsin L Methods Enzymol. 80, 535-61
31. Novinec, M. and Lenarč ič, B. (2013) Cathepsin K: a unique collagenolytic cysteine peptidase Biol. Chem. 394, 1163-1179
32. Wang, B., Sun, J., Kitamoto, S., Yang, M., Grubb, A., Chapman, H. A., Kalluri, R., and Shi, G. P. (2006) Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors J. Biol. Chem. 281, 6020-6029
33. Weissleder, R., Tung, C., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with proteaseactivated near-infrared fluorescent probes Nat. Biotechnol. 17, 375-378
34. Onda, N., Kemmochi, S., Morita, R., Ishihara, Y., and Shibutani, M. (2013) In vivo imaging of tissue-remodeling activity involving infiltration of macrophages by a systemically administered protease-activatable probe in colon cancer tissues Translational Oncology 6, 628-637
35. Nahrendorf, M., Sosnovik, D. E., Waterman, P., Swirski, F. K., Pande, A. N., Aikawa, E., Figueiredo, J., Pittet, M. J., and Weissleder, R. (2007) Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct Circ. Res. 100, 1218-1225
36. Blum, G., Degenfeld, G., Merchant, M. J., Blau, H. M., and Bogyo, M. (2007) Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes Nat. Chem. Biol. 3, 668-667
37. Paulick, M. G. and Bogyo, M. (2011) Development of activity-based probes for cathepsin X ACS Chem. Biol. 6, 563-572
38. Edgington, L. E., Verdoes, M., Ortega, A., Withana, N. P., Lee, J., Syed, S., Bachmann, M. H., Blum, G., and Bogyo, M. (2012) Functional imaging of legumain in cancer using a new quenched activity-based probe J. Am. Chem. Soc. 135, 174-182
39. Edgington, L. E. and Bogyo, M. (2013) In vivo imaging and biochemical characterization of protease function using fluorescent activity-based probes Curr. Protoc. Chem. Biol. 5, 25-44
40. Imai, S., Kiyozuka, Y., Maeda, H., Noda, T., and Hosick, H. L. (1990) Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen Oncology 47, 177-184
41. Hung, M. C., Zhang, X., Yan, D. H., Zhang, H. Z., He, G. P., Zhang, T. Q., and Shi, D. R. (1992) Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer Cancer Lett. 61, 95-103
42. Hamilton, T. C., Young, R. C., and Ozols, R. F. (1984) Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches Semin. Oncol. 11, 285-298
43. Ravanko, K., Järvinen, K., Helin, J., Kalkkinen, N., and Hölttä, E. (2004) Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts Cancer Res. 64, 8831-8838
44. Esser, R. E., Angelo, R. A., Murphey, M. D., Watts, L. M., Thornburg, L. P., Palmer, J. T., Talhouk, J. W., and Smith, R. E. (1994) Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis Arthritis Rheum. 37, 236-247
45. Shaw, E., Mohanty, S., Colic, A., Stoka, V., and Turk, V. (1993) The affinity-labelling of cathepsin S with peptidyl diazomethyl ketones. Comparison with the inhibition of cathepsin L and calpain FEBS Lett. 334, 340-342
46. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., and Katunuma, N. (1991) Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro FEBS Lett. 280, 307-10
47. Steverding, D. (2011) The cathepsin B-Selective inhibitors CA-074 and CA-074Me inactivate cathepsin L under reducing conditions Open Enzyme Inhibition Journal 4, 11-16
48. Asai, M., Yagishita, S., Iwata, N., Saido, T. C., Ishiura, S., and Maruyama, K. (2011) An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model FASEB J. 10, 3720-3730
49. Bogyo, M., Verhelst, S., Bellingard-Dubouchaud, V., Toba, S., and Greenbaum, D. (2000) Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs Chem. Biol. 7, 27-38
50. Boudreau, F., Lussier, C. R., Mongrain, S., Darsigny, M., Drouin, J. L., Doyon, G., Suh, E. R., Beaulieu, J. F., Rivard, N., and Perreault, N. (2007) Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia FASEB J. 21, 3853-3865
51. Chung, J. H., Im, E. K., Jin, T., Lee, S. M., Kim, S. H., Choi, E. Y., Shin, M. J., Lee, K. H., and Jang, Y. (2011) Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration Exp. Mol. Med. 43, 179-188
52. Ivascu, A. and Kubbies, M. (2006) Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis J. Biomol. Screen. 11, 922-932